Apolipoproteins E and C1 and brain morphology in memory impaired elders

Neurogenetics

Volumn 4, Issue 3, 2003, Pages 141-146

  Serra Grabulosa, J M ^a   Salgado Pineda, P ^a   Junque C ^a   Sole Padulles C ^a   Moral, P ^b   Lopez Alomar A ^b   Lopez T ^c   Lopez Guillen A ^d   Bargallo N ^e   Mercader, J M ^e   Clemente, I C ^a   Bartres Faz D ^a,b  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c CAP Lepanto   (Spain)

^d CAP Rambla Sabadell   (Spain)

^e HOSPITAL CLÍNIC   (Spain)

Author keywords

Apolipoproteins; Frontal lobe; Hippocampus; Magnetic resonance imaging; Volumetry

Indexed keywords

APOLIPOPROTEIN C1; APOLIPOPROTEIN E;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; BRAIN REGION; BRAIN SIZE; CLINICAL ARTICLE; COGNITIVE DEFECT; DISEASE ASSOCIATION; FEMALE; FRONTAL LOBE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC PARAMETERS; GENETIC POLYMORPHISM; HEALTH STATUS; HIPPOCAMPUS; HUMAN; LIPID ANALYSIS; MALE; MEMORY DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STRUCTURE ANALYSIS; WHITE MATTER;

EID: 0037949106     PISSN: 13646745     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10048-002-0142-8     Document Type: Article

References (41)

1. Crook TH, Bartus RT, Ferris SH, Whitehouse P, Cohen GD, Gershon S (1986) Age-associated memory impairment: proposed diagnostic criteria and measurements of clinical change. Report of a National Institute of Mental Health workgroup. Dev Neuropsychol 2:261-276
2. Hänninen T, Hallikainen M, Koivisto K, Helkala E-L, Reinikainen KJ, Soininen H, Mykkänen L, Laakso M, Pyöräla K, Riekkinen PJ (1995) A follow-up study of age-associated memory impairment: neuropsychological predictors of dementia. J Am Geriatr Soc 43:1017-1015
3. Helkala E-L, Koivisto K, Hänninen T, Vanhanen M, Kuusisto J, Mykkanen L, Laakso M, Riekkinen P (1997) Stability of age-associated memory impairment during a longitudinal population-based study. J Am Geriatr Soc 45:120-122
4. Hänninen T, Soininen H (1997) Age-associated memory impairment. Normal aging or warning of dementia? Drugs Aging 6:480-489
5. Bamford KA, Caine DE (1988) Does 'benign senescent forgetfulness' exist? Clin Geriatr Med 4:897-916
6. O'Brien J, Levy R(1992) Age associated memory impairment. Too broad an entity to justify drug treatment yet. Lancet 304:5-6
7. Koivisto K, Reinikainen KJ, Hänninen T, Vanhanen M, Helkala E-L, Mykkänen L, Laakso M, Pyorala K, Riekkinen PJ (1995) Prevalence of age-associated memory impairment in a randomly selected population from eastern Finland. Neurology 45:741-747
8. Ritchie K, Leibovici D, Ledésert B, Touchon J (1996) A typology of sub-clinical senescent cognitive disorder. Br J Psychiatry 168:470-476
9. Soininen HS, Partanen K, Pitkänen A, Vainio P, Hänninen T, Hallikainen M, Koivisto K, Riekkinen PJ (1994) Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age-associated memory impairment. Neurology 44:1660-1668
10. Parnetti L, Lowenthal DT, Presciutti O, Pelliccioli G, Palumbo R, Gobbi G, Chiarini P, Palumbo B, Tarducci R, Senin U (1996) 1EMRS, MRI-based hippocampal volumetry, and 99mTc-HMPAO-SPECT in normal aging, age-associated-memory impairment, and probable Alzheimer's disease. J Am Geriatr Soc 44:133-138
11. Hänninen T, Hallikainen M, Koivisto K, Partanen K, Laakso MP, Riekkinen PJ, Soininen H (1997) Decline of frontal lobe functions in subjects with age-associated memory impairment. Neurology 48:148-153
12. Goldman WP, Morris JC (2001) Evidence that age-associated memory impairment is not a normal variant of aging. Alzheimer Dis Assoc Disord 15:72-79
13. Saunders AM, Schmader K, Breitner JCS, Benson MD, Brown WT, Goldfarb I, Goldgaber D, Manwaring MG, Szymanski MH, McCown N, Dole KC, Schmechel DE, Strittmatter WJ, Pericak-Vance MA, Roses AD (1993) Apolipoprotein ε4 allele distributions in late-onset alzheimer's disease and in other amyloid-forming diseases. Lancet 342:710-711
14. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 90:1977-1981
15. Corder EH, Saunders AM, Strittmatter WJ, Schmechel D, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921-923
16. Templeton AR (1995) A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping or DNA sequencing. V. Analysis of case/control sampling designs: Alzheimer's disease and the apolipoprotein E locus. Genetics 140:403-409
17. Scacchi R, Gambina G, Ruggeri M, Martini MC, Ferrari G, Silvestri M, Schiavon R, Corbo RM (1999) Plasma levels of apolipoprotein E and genetic markers in elderly patients with Alzheimer's disease. Neurosci Lett 259:33-36
18. Poduslo SE, Neal M, Scwankhaus J (1995) A closely linked gene to apolipoprotein E may serve as an additional risk factor for Alzheimer's disease. Neurosci Lett 201:81-83
19. Poduslo SE, Neal M, Herring K, Shelly J (1998) The apolipoprotein CI A allele as a risk factor for Alzheimer's disease. Neurochem Res 23:361-367
20. Drigalenko E, Poduslo S, Elston R (1998) Interaction of the apolipoprotein E and CI loci in predisposing to late-onset Alzheimer's disease. Neurology 51:131-135
21. Chang-Seok K, Duk Lyul N, Doh Kwan K, Hye Jim K, Jong-Won K (2002) Genetic association of an apolipoprotein CI (APOC1) gene polymorphism with late-onset Alzheimer's disease. Neurosci Lett 319:75-78
22. Chartier-Harlin M-C, Parfitt M, Legrain S, Pérez-Tur, Brousseau T, Evans A, Berr C, Vidal O, Roques P, Gourlet V, Fruchart J-C, Delacourte A, Rossor M, Amouyel P (1994) Apolipoprotein E, ε4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet 3:569-574
23. Tysoe C, Galinsky D, Robinson D, Brayne C, Huppert FA, Dening T, Paykel ES, Easton DF, Rubinsztein DC (1998) Apo E and Apo CI loci are associated with dementia in younger but not older late-onset cases. Dement Geriatr Cogn Disord 9:191-198
24. Bartrés-Faz D, Clemente IC, Valveny N, López-Alomar A, Sánchez-Aldeguer J, López-Guillén A, Moral P (2001) APOE and APOC1 genetic polymorphisms in age-associated memory impairment. Neurogenetics 3:215-219
25. Bartrés-Faz D, Junqué C, Clemente IC, Serra-Grabulosa JM, Guardia J, López-Alomar A, Sánchez-Aldeguer J, Mercader JM, Bargalló N, Olondo, Moral P (2001) MRI and genetic correlates of cognitive function in elders with memory impairment. Neurobiol Aging 22:449-459
26. Lehtovirta M, Laakso MP, Frisoni GB, Soininen H (2000) How does the apolipoprotein E genotype modulate the brain in aging and in Alzheimer's disease? A review of neuroimaging studies. Neurobiol Aging 21:293-300
27. Geroldi C, Pihlajamäki M, Laakso MP, DeCarli C, Beltramello A, Bianchetti A, Soininen H, Trabucchi M, Frisoni GB (1999) APOE-ε4 is associated with less frontal and more medial temporal lobe atrophy in AD. Neurology 53:1825-1832
28. Yasuda M, Mori E, Kitagaki H, Yamashita H, Hirono N, Shimada K, Maeda K, Tanaka C. (1998) Apolipoprotein E ε4 allele and whole brain atrophy in late-onset Alzheimer's disease. Am J Psychiatry 155:779-784
29. Hashimoto M, Yasuda M, Tanimukai S, Matsui M, Hirono N, Kazui H, Mori E (2001) Apolipoprotein E epsilon 4 and the pattern of regional brain atrophy in Alzheimer's disease. Neurology 57:1461-1466
30. Squire LR, Zola-Morgan S (1986) The medial temporal lobe memory system. Science 253:1380-1386
31. Lezak MD (1995) Neuropsychological assessment. Oxford University Press, New York
32. Nillesen WM, Smeets HJM, Van Oost BA (1990) Human Apo CI HpaI restriction site polymorphism reveladed by the polymerase chain reaction. Nucleic Acids Res 18:3428
33. Wenham PR, Price WH, Blandell G (1991) Apolipoprotein E genotyping by one-stage PCR. Lancet 337:1158-1159
34. Jack CR, Petersen RC, Xu YC, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Waring SC, Tangalos EG, Kokmen E (1999) Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 52:1397-1403
35. Jack CR, Tworney CK, Zinsmeister AR, Sharborough FW, Petersen RC, Cascino GD (1989) Anterior temporal lobes and hippocampal formations: normative volumetric measurements from MR images in young adults. Radiology 172:549-554
36. Free SL, Bergin PS, Fish DR, Cook MJ, Shorvon SD, Stevens JM (1995) Methods for normalization of hippocampal volumes measured with MR. Am J Neuroradiol 16:637-643
37. Petersen RC, Smith GE, Waring SC, Ivnik R, Tangalos EG, Kokmen E (1999) Mild cognitive impairment. Clinical characterisation and outcome. Arch Neurol 56:303-308
38. Bigler ED, Lowry CM, Anderson CV, Johnson SC, Terry J, Steed M (2000) Dementia, quantitative neuroimaging and apolipoprotein E genotype. Am J Neuroradiol 21:1857-1868
39. Jong MC, Van Dijk KW, Dahlmans VEH, Van Der Boom H, Kobayashi K, Oka K, Siest G, Chan L, Hofker MH, Havekes LM (1999) Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor. Biochem J 338:281-287
40. Xu Y, Berglund L, Ramakrishnan R, Mayeux R, Ngai C, Holleran S, Tycko B, Tycko B, Leff T, Shacher NS (1999) A common Hpa I RFLP of apolipoprotein C-I increases gene transcription and exhibits an ethnically distinct pattern of linkage disequilibrium with the alleles of apolipoprotein E. J Lipid Res 40:50-58
41. Petit-Turcotte C, Stohl SM, Beffert U, Cohn JS, Aumont N, Trembaly M, Dea D, Yang L, Poirier J, Shachter NS (2001). Apolipoprotein C-I expression in the brain in Alzheimer's disease. Neurobiol Dis 8:953-963